Related Experiment Video
Updated: Apr 26, 2026

Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices
Published on: June 13, 2025
[The ways of prophylaxis of the gastro-intestinal hemorrhage recurrence]
Insights
This study treated 57 gastro-intestinal hemorrhage (GIH) patients with ulcer genesis, achieving no recurrence through a comprehensive treatment program. Effective management ensured patient recovery and prolonged conservative therapy.
Area of Science:
- Gastroenterology
- Internal Medicine
Context:
- Gastro-intestinal hemorrhage (GIH) is a significant clinical challenge.
- Ulcer genesis is a common cause of GIH.
Purpose:
- To evaluate the effectiveness of a comprehensive treatment program for gastro-intestinal hemorrhage (GIH) originating from ulcers.
- To assess the recurrence rates and patient outcomes following treatment.
Summary:
- Fifty-seven patients with ulcer-related GIH were treated over three years.
- Treatment included local hemostasis, fluid resuscitation, gastric secretion inhibition, coagulation enhancement, and blood product transfusion for moderate to severe cases.
- Three patients required surgery; no GIH recurrence was observed.
Impact:
- The study demonstrates a successful multi-modal treatment approach for ulcer-related GIH.
- Achieving persistent hemostasis led to successful patient transfer for continued conservative therapy.
- The findings support the efficacy of the described treatment protocol in managing GIH and preventing recurrence.
Abstract:
Through three-years period 57 patients, suffering gastro-intestinal hemorrhage (GIH) of the ulcer genesis, were treated in the clinic. Among them were 37 (64.9%) men and 20 (35.1%) women. The patients have had (56.3 +/- 4.7) yrs old at average. The treatment programm for the patients have included a local arrest of GIH, medicinal therapy, directed on restoration of the circulating blood volume, gastric secretion inhibition, rising of the blood coagulation property. In cases of a middle and severe blood loss the blood preparations were transfused--the erythrocytic mass and freshly frozen plasm. Three patients were operated in the high period of GIH. The GIH recurrence was absent. In 7 - 8 days, if a persistent hemostasis was achieved, the patients were transferred to therapeutic department for the conservative therapy prolongation.
Related Concept Videos
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Prevention of Further Absorption of Poison
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Venous Thrombosis III: Interprofessional Care